Intellectual Property (IP) information
Referencing information
Open access to bibliographic metadata that identify the deposited publication will also be ensured. The bibliographic metadata will be in a standard format and will include the following:
- The terms [“European Union (EU)” and “EDCTP”]
- The name of the action, acronym and grant number;
- The publication date and length of embargo period if applicable, and a persistent DATURA identifier.
All presentations and publications will mention that “This research was funded by the EDCTP2 programme (grant RIA2018-CO-2515) supported by the European Union and Inserm-ANRS, which was the sponsor of the research (ANRS 12424 DATURA) and the funder of the Asian component”.
The name of all investigators who enrolled or followed patients in the trial, the composition of the Project Steering Committee and of the Data and Safety Monitoring Board will be mentioned in the main publication.
The Project Steering Committee alone will be competent to decide upon the mention of any other person in publications relative to the trial, if it thinks this is justified.
In case of ancillary studies, results may only be published after publication of the results from the main trial and should mention that “this study is an ancillary study of the DATURA trial, which was funded by the EDCTP2 programme (grant RIA2018-CO-2515) supported by the European Union and Inserm-ANRS, which was the sponsor of the research (ANRS 12424 DATURA) and the funder of the Asian component”.